Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients

Otaegui, David; Baranzini, Sergio E.; Armañanzas Arnedillo, Ruben; Calvo, Borja; Muñoz Culla, Maider; Khankhanian, Puya; Inza Cano, Iñaki; Lozano, Jose Antonio; Asensio, Ana; Olaskoaga, Javier y López de Munain, Adolfo (2009). Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients. "Plos One", v. 4 (n. 7); pp. 1-9. ISSN 1932-6203. https://doi.org/10.1371/journal.pone.0006309.


Título: Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients
  • Otaegui, David
  • Baranzini, Sergio E.
  • Armañanzas Arnedillo, Ruben
  • Calvo, Borja
  • Muñoz Culla, Maider
  • Khankhanian, Puya
  • Inza Cano, Iñaki
  • Lozano, Jose Antonio
  • Asensio, Ana
  • Olaskoaga, Javier
  • López de Munain, Adolfo
Tipo de Documento: Artículo
Título de Revista/Publicación: Plos One
Fecha: 2009
Volumen: 4
Escuela: Facultad de Informática (UPM) [antigua denominación]
Departamento: Otro
Licencias Creative Commons: Reconocimiento - Sin obra derivada - No comercial

Texto completo

Vista Previa
PDF (Document Portable Format) - Se necesita un visor de ficheros PDF, como GSview, Xpdf o Adobe Acrobat Reader
Descargar (586kB) | Vista Previa


Differences in gene expression patterns have been documented not only in Multiple Sclerosis patients versus healthy controls but also in the relapse of the disease. Recently a new gene expression modulator has been identified: the microRNA or miRNA. The aim of this work is to analyze the possible role of miRNAs in multiple sclerosis, focusing on the relapse stage. We have analyzed the expression patterns of 364 miRNAs in PBMC obtained from multiple sclerosis patients in relapse status, in remission status and healthy controls. The expression patterns of the miRNAs with significantly different expression were validated in an independent set of samples. In order to determine the effect of the miRNAs, the expression of some predicted target genes of these were studied by qPCR. Gene interaction networks were constructed in order to obtain a co-expression and multivariate view of the experimental data. The data analysis and later validation reveal that two miRNAs (hsa-miR-18b and hsa-miR-599) may be relevant at the time of relapse and that another miRNA (hsa-miR-96) may be involved in remission. The genes targeted by hsa-miR-96 are involved in immunological pathways as Interleukin signaling and in other pathways as wnt signaling. This work highlights the importance of miRNA expression in the molecular mechanisms implicated in the disease. Moreover, the proposed involvement of these small molecules in multiple sclerosis opens up a new therapeutic approach to explore and highlight some candidate biomarker targets in MS

Más información

ID de Registro: 13938
Identificador DC: http://oa.upm.es/13938/
Identificador OAI: oai:oa.upm.es:13938
Identificador DOI: 10.1371/journal.pone.0006309
URL Oficial: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006309
Depositado por: Memoria Investigacion
Depositado el: 21 Dic 2012 11:34
Ultima Modificación: 21 Abr 2016 13:22
  • Open Access
  • Open Access
  • Sherpa-Romeo
    Compruebe si la revista anglosajona en la que ha publicado un artículo permite también su publicación en abierto.
  • Dulcinea
    Compruebe si la revista española en la que ha publicado un artículo permite también su publicación en abierto.
  • Recolecta
  • e-ciencia
  • Observatorio I+D+i UPM
  • OpenCourseWare UPM